1. Home
  2. MNKD vs AWF Comparison

MNKD vs AWF Comparison

Compare MNKD & AWF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$3.52

Market Cap

877.0M

Sector

Health Care

ML Signal

HOLD

Logo Alliancebernstein Global High Income Fund

AWF

Alliancebernstein Global High Income Fund

HOLD

Current Price

$10.29

Market Cap

868.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNKD
AWF
Founded
1991
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
877.0M
868.3M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
MNKD
AWF
Price
$3.52
$10.29
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$8.69
N/A
AVG Volume (30 Days)
6.3M
604.1K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
7.57%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$348,966,000.00
N/A
Revenue This Year
$35.81
N/A
Revenue Next Year
$11.89
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.23
N/A
52 Week Low
$2.23
$9.85
52 Week High
$6.51
$11.43

Technical Indicators

Market Signals
Indicator
MNKD
AWF
Relative Strength Index (RSI) 64.71 52.40
Support Level $2.45 $9.99
Resistance Level $6.08 $10.58
Average True Range (ATR) 0.26 0.11
MACD 0.02 0.01
Stochastic Oscillator 43.01 66.32

Price Performance

Historical Comparison
MNKD
AWF

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

About AWF Alliancebernstein Global High Income Fund

Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.

Share on Social Networks: